Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial.

guest :: login DZNEPUB
		Search		Submit		Personalize Your alerts Your baskets Your searches		Help

Home > Publications Database > Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial. > Access to Fulltext

Information
Files

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial. - DZNE-2025-00461

Restricted fulltext file(s):

Similar records

DZNEPUB :: :: :: ::
Powered by v1.1.7 |
Maintained by

Impressum | Data Privacy Policy